intErnet-based iNterventions FOR Cardiac arrEst suRvivors
Launched by AZIENDA USL DI BOLOGNA · Apr 30, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how an internet-based lifestyle program can help people who have survived a cardiac arrest but are experiencing anxiety, depression, or cognitive difficulties. The goal is to see if using a web app can improve these mental health symptoms and enhance the overall quality of life for these patients.
To participate in this study, you need to have been discharged from the hospital after experiencing a cardiac arrest and have mild to moderate anxiety or depression. You should be between 65 and 74 years old or 29 to 219 years old, be able to understand Italian, and be comfortable using the internet. If you join the trial, you will have access to helpful resources and support through the web app, which aims to improve your emotional well-being and daily functioning. This study is currently recruiting participants, so if you think you might qualify, it could be a good opportunity to get support and help.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Hospital discharge after out-of-hospital cardiac arrest with Cerebral Performance Category 1 or 2
- • HADS anxiety or depression ≥ 8 and/or TICS ≤ 31
- • Informed consent for participation in the study
- • Native Italian speaker or adequate understanding of the Italian language
- • Adequate ability to use the web to guarantee access to the contents
- Exclusion Criteria:
- • Previous cognitive dysfunction
- • Previous psychiatric disease
- • Previous episode of out-of-hospital cardiac arrest
About Azienda Usl Di Bologna
Azienda USL di Bologna is a prominent public healthcare organization based in Bologna, Italy, dedicated to providing high-quality medical services and advancing public health initiatives. As a clinical trial sponsor, it plays a critical role in facilitating innovative research that enhances patient care and supports the development of new therapeutic interventions. The organization collaborates with a network of healthcare professionals, academic institutions, and industry partners to conduct rigorous clinical studies, ensuring adherence to ethical standards and regulatory requirements. With a commitment to improving healthcare outcomes, Azienda USL di Bologna actively contributes to the generation of evidence-based practices in the medical field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bologna, , Italy
Imola, Bologna, Italy
Patients applied
Trial Officials
Lorenzo Gamberini, MD
Principal Investigator
Azienda USL Bologna
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported